Description
Cagrilintide 5mg – Advanced Amylin Analog for Appetite and Weight Regulation Research
Cagrilintide 5mg is an innovative peptide formulation developed to support appetite suppression, weight loss, and metabolic health. As a novel amylin receptor agonist, Cagrilintide works synergistically with GLP-1 receptor agonists to enhance satiety, delay gastric emptying, and reduce food intake, making it a promising candidate in obesity and metabolic research.
Manufactured to high purity standards, each vial delivers 5mg of Cagrilintide—ideal for consistent results in both preclinical and clinical research environments. Its dual mechanism targets the central nervous system and digestive tract, helping regulate hunger signals and calorie consumption.
Key Features:
-
5mg lyophilized Cagrilintide peptide per vial
-
Promotes long-lasting satiety and appetite control
-
Complements GLP-1-based therapies for enhanced weight loss
-
Supports insulin sensitivity and metabolic health
-
Ideal for research in weight management and metabolic disorders
⚠️ For Research Use Only. Not for Human Consumption.
This compound is sold strictly for in vitro laboratory research purposes only. It is not intended for human or veterinary use, nor for diagnostic or therapeutic purposes. No claims are made regarding safety or efficacy in any clinical application.Disclaimer:
All information provided is for educational and scientific reference only. Statements have not been evaluated by the FDA or any medical regulatory body. This product is not a drug or supplement. Buyer assumes all responsibility for lawful use and compliance with applicable regulations.Terms of Sale:
By purchasing from LIBERTY LABS, you confirm that you are a qualified researcher or institution equipped to handle this material safely. You accept full responsibility for its use and understand that Liberty Labs assumes no liability for misuse, misinterpretation, or improper application of this compound. ALL SALES FINAL